nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—ganglion—brain cancer	0.018	0.0604	CbGeAlD
Pemetrexed—GART—One Carbon Metabolism—DNMT1—brain cancer	0.0163	0.0701	CbGpPWpGaD
Pemetrexed—ATIC—One Carbon Metabolism—DNMT1—brain cancer	0.0113	0.0486	CbGpPWpGaD
Pemetrexed—GART—telencephalon—brain cancer	0.0102	0.0343	CbGeAlD
Pemetrexed—GART—gonad—brain cancer	0.00852	0.0286	CbGeAlD
Pemetrexed—GART—pituitary gland—brain cancer	0.00831	0.0279	CbGeAlD
Pemetrexed—GART—medulla oblongata—brain cancer	0.00802	0.027	CbGeAlD
Pemetrexed—TYMS—Podofilox—Etoposide—brain cancer	0.00787	1	CbGdCrCtD
Pemetrexed—ATIC—brainstem—brain cancer	0.00781	0.0263	CbGeAlD
Pemetrexed—DHFR—E2F transcription factor network—HIC1—brain cancer	0.00739	0.0319	CbGpPWpGaD
Pemetrexed—GART—midbrain—brain cancer	0.00733	0.0246	CbGeAlD
Pemetrexed—GART—spinal cord—brain cancer	0.00715	0.024	CbGeAlD
Pemetrexed—ATIC—telencephalon—brain cancer	0.00693	0.0233	CbGeAlD
Pemetrexed—SLC46A1—pituitary gland—brain cancer	0.00675	0.0227	CbGeAlD
Pemetrexed—TYMS—E2F transcription factor network—HIC1—brain cancer	0.00645	0.0278	CbGpPWpGaD
Pemetrexed—GART—endocrine gland—brain cancer	0.00644	0.0216	CbGeAlD
Pemetrexed—GART—head—brain cancer	0.00636	0.0214	CbGeAlD
Pemetrexed—SLC46A1—spinal cord—brain cancer	0.00581	0.0195	CbGeAlD
Pemetrexed—GART—central nervous system—brain cancer	0.0058	0.0195	CbGeAlD
Pemetrexed—ATIC—gonad—brain cancer	0.00578	0.0194	CbGeAlD
Pemetrexed—GART—Folate Metabolism—SOD2—brain cancer	0.0057	0.0245	CbGpPWpGaD
Pemetrexed—GART—cerebellum—brain cancer	0.00567	0.0191	CbGeAlD
Pemetrexed—SLC46A1—endocrine gland—brain cancer	0.00523	0.0176	CbGeAlD
Pemetrexed—SLC46A1—head—brain cancer	0.00516	0.0173	CbGeAlD
Pemetrexed—DHFR—G1/S-Specific Transcription—CCNE1—brain cancer	0.00501	0.0216	CbGpPWpGaD
Pemetrexed—ATIC—midbrain—brain cancer	0.00498	0.0167	CbGeAlD
Pemetrexed—ATIC—spinal cord—brain cancer	0.00486	0.0163	CbGeAlD
Pemetrexed—SLC46A1—central nervous system—brain cancer	0.00471	0.0158	CbGeAlD
Pemetrexed—DHFR—One Carbon Metabolism—DNMT1—brain cancer	0.00471	0.0203	CbGpPWpGaD
Pemetrexed—TYMS—telencephalon—brain cancer	0.0047	0.0158	CbGeAlD
Pemetrexed—DHFR—telencephalon—brain cancer	0.00465	0.0156	CbGeAlD
Pemetrexed—GART—brain—brain cancer	0.00461	0.0155	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—brain cancer	0.0046	0.0155	CbGeAlD
Pemetrexed—DHFR—G1/S-Specific Transcription—PCNA—brain cancer	0.00444	0.0191	CbGpPWpGaD
Pemetrexed—ATIC—endocrine gland—brain cancer	0.00437	0.0147	CbGeAlD
Pemetrexed—TYMS—G1/S-Specific Transcription—CCNE1—brain cancer	0.00437	0.0188	CbGpPWpGaD
Pemetrexed—ATIC—head—brain cancer	0.00432	0.0145	CbGeAlD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00423	0.0182	CbGpPWpGaD
Pemetrexed—SLC29A1—telencephalon—brain cancer	0.00422	0.0142	CbGeAlD
Pemetrexed—TYMS—One Carbon Metabolism—DNMT1—brain cancer	0.00411	0.0177	CbGpPWpGaD
Pemetrexed—DCK—telencephalon—brain cancer	0.00403	0.0135	CbGeAlD
Pemetrexed—ATIC—central nervous system—brain cancer	0.00394	0.0132	CbGeAlD
Pemetrexed—TYMS—gonad—brain cancer	0.00392	0.0132	CbGeAlD
Pemetrexed—DHFR—gonad—brain cancer	0.00388	0.0131	CbGeAlD
Pemetrexed—TYMS—G1/S-Specific Transcription—PCNA—brain cancer	0.00387	0.0167	CbGpPWpGaD
Pemetrexed—ATIC—cerebellum—brain cancer	0.00385	0.0129	CbGeAlD
Pemetrexed—DHFR—pituitary gland—brain cancer	0.00379	0.0127	CbGeAlD
Pemetrexed—Haemolytic anaemia—Procarbazine—brain cancer	0.00378	0.00816	CcSEcCtD
Pemetrexed—SLC46A1—brain—brain cancer	0.00374	0.0126	CbGeAlD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00369	0.0159	CbGpPWpGaD
Pemetrexed—DHFR—medulla oblongata—brain cancer	0.00366	0.0123	CbGeAlD
Pemetrexed—SLC29A1—gonad—brain cancer	0.00352	0.0118	CbGeAlD
Pemetrexed—Skin exfoliation—Hydroxyurea—brain cancer	0.00347	0.0075	CcSEcCtD
Pemetrexed—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00345	0.00746	CcSEcCtD
Pemetrexed—SLC29A1—pituitary gland—brain cancer	0.00343	0.0115	CbGeAlD
Pemetrexed—TYMS—midbrain—brain cancer	0.00338	0.0114	CbGeAlD
Pemetrexed—DCK—gonad—brain cancer	0.00336	0.0113	CbGeAlD
Pemetrexed—DHFR—midbrain—brain cancer	0.00334	0.0112	CbGeAlD
Pemetrexed—GART—Folate Metabolism—RELA—brain cancer	0.00329	0.0142	CbGpPWpGaD
Pemetrexed—Alopecia—Lomustine—brain cancer	0.00328	0.0071	CcSEcCtD
Pemetrexed—DCK—pituitary gland—brain cancer	0.00328	0.011	CbGeAlD
Pemetrexed—DHFR—spinal cord—brain cancer	0.00326	0.011	CbGeAlD
Pemetrexed—Interstitial lung disease—Etoposide—brain cancer	0.00321	0.00694	CcSEcCtD
Pemetrexed—DCK—medulla oblongata—brain cancer	0.00316	0.0106	CbGeAlD
Pemetrexed—ATIC—brain—brain cancer	0.00313	0.0105	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—SOD2—brain cancer	0.00308	0.0133	CbGpPWpGaD
Pemetrexed—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00307	0.00664	CcSEcCtD
Pemetrexed—Infection—Carboplatin—brain cancer	0.003	0.00648	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—IL2—brain cancer	0.00297	0.0128	CbGpPWpGaD
Pemetrexed—TYMS—endocrine gland—brain cancer	0.00297	0.00997	CbGeAlD
Pemetrexed—Dysphagia—Procarbazine—brain cancer	0.00295	0.00637	CcSEcCtD
Pemetrexed—DHFR—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.00295	0.0127	CbGpPWpGaD
Pemetrexed—Pulmonary embolism—Carmustine—brain cancer	0.00294	0.00635	CcSEcCtD
Pemetrexed—DHFR—endocrine gland—brain cancer	0.00294	0.00987	CbGeAlD
Pemetrexed—TYMS—head—brain cancer	0.00293	0.00984	CbGeAlD
Pemetrexed—DHFR—head—brain cancer	0.0029	0.00974	CbGeAlD
Pemetrexed—Leukopenia—Lomustine—brain cancer	0.0029	0.00626	CcSEcCtD
Pemetrexed—Respiratory failure—Temozolomide—brain cancer	0.00289	0.00625	CcSEcCtD
Pemetrexed—DCK—midbrain—brain cancer	0.00289	0.00972	CbGeAlD
Pemetrexed—Pancreatitis—Procarbazine—brain cancer	0.00289	0.00625	CcSEcCtD
Pemetrexed—Angina pectoris—Procarbazine—brain cancer	0.00287	0.00621	CcSEcCtD
Pemetrexed—Renal failure acute—Hydroxyurea—brain cancer	0.00286	0.00618	CcSEcCtD
Pemetrexed—Pulmonary embolism—Temozolomide—brain cancer	0.00284	0.00614	CcSEcCtD
Pemetrexed—DCK—spinal cord—brain cancer	0.00282	0.00949	CbGeAlD
Pemetrexed—Skin exfoliation—Carmustine—brain cancer	0.00281	0.00607	CcSEcCtD
Pemetrexed—Pancytopenia—Procarbazine—brain cancer	0.0028	0.00605	CcSEcCtD
Pemetrexed—Neuropathy—Carmustine—brain cancer	0.00276	0.00596	CcSEcCtD
Pemetrexed—Skin exfoliation—Temozolomide—brain cancer	0.00271	0.00586	CcSEcCtD
Pemetrexed—TYMS—central nervous system—brain cancer	0.00267	0.00898	CbGeAlD
Pemetrexed—Neuropathy—Temozolomide—brain cancer	0.00267	0.00576	CcSEcCtD
Pemetrexed—SLC29A1—endocrine gland—brain cancer	0.00266	0.00894	CbGeAlD
Pemetrexed—DHFR—central nervous system—brain cancer	0.00265	0.00889	CbGeAlD
Pemetrexed—SLC29A1—head—brain cancer	0.00262	0.00883	CbGeAlD
Pemetrexed—Infection—Lomustine—brain cancer	0.00262	0.00567	CcSEcCtD
Pemetrexed—TYMS—cerebellum—brain cancer	0.00261	0.00878	CbGeAlD
Pemetrexed—DHFR—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.00261	0.0113	CbGpPWpGaD
Pemetrexed—DHFR—cerebellum—brain cancer	0.00259	0.00869	CbGeAlD
Pemetrexed—Thrombocytopenia—Lomustine—brain cancer	0.00258	0.00559	CcSEcCtD
Pemetrexed—Pain—Carboplatin—brain cancer	0.00258	0.00558	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Procarbazine—brain cancer	0.00258	0.00557	CcSEcCtD
Pemetrexed—TYMS—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.00257	0.0111	CbGpPWpGaD
Pemetrexed—Stomatitis—Procarbazine—brain cancer	0.00256	0.00554	CcSEcCtD
Pemetrexed—Sepsis—Carmustine—brain cancer	0.00255	0.00551	CcSEcCtD
Pemetrexed—DCK—endocrine gland—brain cancer	0.00254	0.00854	CbGeAlD
Pemetrexed—Anorexia—Lomustine—brain cancer	0.00252	0.00544	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00252	0.0108	CbGpPWpGaD
Pemetrexed—DCK—head—brain cancer	0.00251	0.00843	CbGeAlD
Pemetrexed—Blood creatinine increased—Hydroxyurea—brain cancer	0.00247	0.00534	CcSEcCtD
Pemetrexed—SLC29A1—central nervous system—brain cancer	0.0024	0.00806	CbGeAlD
Pemetrexed—Body temperature increased—Carboplatin—brain cancer	0.00239	0.00516	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00236	0.0102	CbGpPWpGaD
Pemetrexed—SLC29A1—cerebellum—brain cancer	0.00234	0.00787	CbGeAlD
Pemetrexed—Decreased appetite—Lomustine—brain cancer	0.0023	0.00496	CcSEcCtD
Pemetrexed—DCK—central nervous system—brain cancer	0.00229	0.0077	CbGeAlD
Pemetrexed—TYMS—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.00228	0.00982	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.00224	0.00966	CbGpPWpGaD
Pemetrexed—DCK—cerebellum—brain cancer	0.00224	0.00752	CbGeAlD
Pemetrexed—Pancreatitis—Hydroxyurea—brain cancer	0.00224	0.00483	CcSEcCtD
Pemetrexed—Skin exfoliation—Etoposide—brain cancer	0.00217	0.00469	CcSEcCtD
Pemetrexed—Pancytopenia—Hydroxyurea—brain cancer	0.00217	0.00468	CcSEcCtD
Pemetrexed—Neuropathy—Etoposide—brain cancer	0.00213	0.00461	CcSEcCtD
Pemetrexed—Neutropenia—Hydroxyurea—brain cancer	0.00213	0.00461	CcSEcCtD
Pemetrexed—TYMS—brain—brain cancer	0.00212	0.00713	CbGeAlD
Pemetrexed—Arrhythmia—Procarbazine—brain cancer	0.00211	0.00456	CcSEcCtD
Pemetrexed—DHFR—brain—brain cancer	0.0021	0.00706	CbGeAlD
Pemetrexed—Body temperature increased—Lomustine—brain cancer	0.00209	0.00451	CcSEcCtD
Pemetrexed—Alopecia—Procarbazine—brain cancer	0.00208	0.00451	CcSEcCtD
Pemetrexed—Oesophagitis—Etoposide—brain cancer	0.00208	0.00449	CcSEcCtD
Pemetrexed—Infestation—Hydroxyurea—brain cancer	0.00203	0.0044	CcSEcCtD
Pemetrexed—Infestation NOS—Hydroxyurea—brain cancer	0.00203	0.0044	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00202	0.00871	CbGpPWpGaD
Pemetrexed—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00199	0.00431	CcSEcCtD
Pemetrexed—Stomatitis—Hydroxyurea—brain cancer	0.00198	0.00429	CcSEcCtD
Pemetrexed—Sepsis—Etoposide—brain cancer	0.00197	0.00426	CcSEcCtD
Pemetrexed—Mood swings—Temozolomide—brain cancer	0.00195	0.00422	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00192	0.00416	CcSEcCtD
Pemetrexed—Dehydration—Temozolomide—brain cancer	0.00192	0.00414	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—TP53—brain cancer	0.0019	0.00821	CbGpPWpGaD
Pemetrexed—SLC29A1—brain—brain cancer	0.0019	0.0064	CbGeAlD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.0019	0.00819	CbGpPWpGaD
Pemetrexed—Anaemia—Procarbazine—brain cancer	0.0019	0.0041	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00186	0.00401	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00186	0.00401	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—NTRK3—brain cancer	0.00185	0.00797	CbGpPWpGaD
Pemetrexed—Dysphagia—Carmustine—brain cancer	0.00184	0.00399	CcSEcCtD
Pemetrexed—Syncope—Procarbazine—brain cancer	0.00184	0.00398	CcSEcCtD
Pemetrexed—Leukopenia—Procarbazine—brain cancer	0.00184	0.00397	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00182	0.00393	CcSEcCtD
Pemetrexed—DCK—brain—brain cancer	0.00182	0.00611	CbGeAlD
Pemetrexed—Loss of consciousness—Procarbazine—brain cancer	0.00181	0.0039	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.0018	0.00776	CbGpPWpGaD
Pemetrexed—Dysphagia—Temozolomide—brain cancer	0.00178	0.00385	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—RELA—brain cancer	0.00178	0.00766	CbGpPWpGaD
Pemetrexed—Hypertension—Procarbazine—brain cancer	0.00177	0.00383	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00176	0.0076	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00176	0.00757	CbGpPWpGaD
Pemetrexed—Pancytopenia—Carmustine—brain cancer	0.00175	0.00379	CcSEcCtD
Pemetrexed—Myalgia—Procarbazine—brain cancer	0.00175	0.00378	CcSEcCtD
Pemetrexed—Arthralgia—Procarbazine—brain cancer	0.00175	0.00378	CcSEcCtD
Pemetrexed—Neutropenia—Carmustine—brain cancer	0.00172	0.00373	CcSEcCtD
Pemetrexed—Pancytopenia—Temozolomide—brain cancer	0.00169	0.00366	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00169	0.00728	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—SKP2—brain cancer	0.00169	0.00727	CbGpPWpGaD
Pemetrexed—Vomiting—Lomustine—brain cancer	0.00168	0.00363	CcSEcCtD
Pemetrexed—Oedema—Procarbazine—brain cancer	0.00168	0.00362	CcSEcCtD
Pemetrexed—Neutropenia—Temozolomide—brain cancer	0.00167	0.0036	CcSEcCtD
Pemetrexed—Infection—Procarbazine—brain cancer	0.00167	0.0036	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00166	0.00715	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—SOD2—brain cancer	0.00165	0.00711	CbGpPWpGaD
Pemetrexed—Shock—Procarbazine—brain cancer	0.00165	0.00356	CcSEcCtD
Pemetrexed—Thrombocytopenia—Procarbazine—brain cancer	0.00164	0.00355	CcSEcCtD
Pemetrexed—Renal failure—Carmustine—brain cancer	0.00162	0.00349	CcSEcCtD
Pemetrexed—Alopecia—Hydroxyurea—brain cancer	0.00161	0.00349	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Carmustine—brain cancer	0.00161	0.00348	CcSEcCtD
Pemetrexed—Stomatitis—Carmustine—brain cancer	0.0016	0.00346	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL2—brain cancer	0.0016	0.0069	CbGpPWpGaD
Pemetrexed—Anorexia—Procarbazine—brain cancer	0.0016	0.00345	CcSEcCtD
Pemetrexed—Erythema—Hydroxyurea—brain cancer	0.00159	0.00344	CcSEcCtD
Pemetrexed—Infestation NOS—Temozolomide—brain cancer	0.00159	0.00343	CcSEcCtD
Pemetrexed—Infestation—Temozolomide—brain cancer	0.00159	0.00343	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—SIRT1—brain cancer	0.00158	0.00681	CbGpPWpGaD
Pemetrexed—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00158	0.0034	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.00157	0.00677	CbGpPWpGaD
Pemetrexed—Nausea—Lomustine—brain cancer	0.00157	0.00339	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CCNE1—brain cancer	0.00156	0.00673	CbGpPWpGaD
Pemetrexed—Neuropathy peripheral—Temozolomide—brain cancer	0.00156	0.00337	CcSEcCtD
Pemetrexed—Stomatitis—Temozolomide—brain cancer	0.00155	0.00335	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00153	0.0033	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Temozolomide—brain cancer	0.0015	0.00325	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.0015	0.00645	CbGpPWpGaD
Pemetrexed—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00149	0.00321	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—SKP2—brain cancer	0.00147	0.00635	CbGpPWpGaD
Pemetrexed—Anaemia—Hydroxyurea—brain cancer	0.00147	0.00318	CcSEcCtD
Pemetrexed—Decreased appetite—Procarbazine—brain cancer	0.00146	0.00315	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Etoposide—brain cancer	0.00146	0.00315	CcSEcCtD
Pemetrexed—Fatigue—Procarbazine—brain cancer	0.00145	0.00312	CcSEcCtD
Pemetrexed—Pain—Procarbazine—brain cancer	0.00143	0.0031	CcSEcCtD
Pemetrexed—Constipation—Procarbazine—brain cancer	0.00143	0.0031	CcSEcCtD
Pemetrexed—Hepatitis—Temozolomide—brain cancer	0.00143	0.00308	CcSEcCtD
Pemetrexed—Dysphagia—Etoposide—brain cancer	0.00143	0.00308	CcSEcCtD
Pemetrexed—Leukopenia—Hydroxyurea—brain cancer	0.00142	0.00308	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—SKP2—brain cancer	0.00142	0.00613	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—brain cancer	0.00142	0.00612	CbGpPWpGaD
Pemetrexed—Pharyngitis—Temozolomide—brain cancer	0.00142	0.00306	CcSEcCtD
Pemetrexed—Urinary tract disorder—Temozolomide—brain cancer	0.00141	0.00304	CcSEcCtD
Pemetrexed—Urethral disorder—Temozolomide—brain cancer	0.0014	0.00302	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00139	0.00601	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—SIRT1—brain cancer	0.00138	0.00595	CbGpPWpGaD
Pemetrexed—Eye disorder—Carmustine—brain cancer	0.00138	0.00298	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Procarbazine—brain cancer	0.00137	0.00296	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CCNE1—brain cancer	0.00136	0.00587	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00136	0.00585	CbGpPWpGaD
Pemetrexed—Pancytopenia—Etoposide—brain cancer	0.00135	0.00293	CcSEcCtD
Pemetrexed—Erythema multiforme—Temozolomide—brain cancer	0.00135	0.00292	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00134	0.0029	CcSEcCtD
Pemetrexed—Neutropenia—Etoposide—brain cancer	0.00133	0.00288	CcSEcCtD
Pemetrexed—Eye disorder—Temozolomide—brain cancer	0.00133	0.00288	CcSEcCtD
Pemetrexed—Urticaria—Procarbazine—brain cancer	0.00133	0.00288	CcSEcCtD
Pemetrexed—Abdominal pain—Procarbazine—brain cancer	0.00133	0.00286	CcSEcCtD
Pemetrexed—Body temperature increased—Procarbazine—brain cancer	0.00133	0.00286	CcSEcCtD
Pemetrexed—Arrhythmia—Carmustine—brain cancer	0.00132	0.00285	CcSEcCtD
Pemetrexed—Alopecia—Carmustine—brain cancer	0.0013	0.00282	CcSEcCtD
Pemetrexed—Oedema—Hydroxyurea—brain cancer	0.0013	0.0028	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00129	0.00557	CbGpPWpGaD
Pemetrexed—Infection—Hydroxyurea—brain cancer	0.00129	0.00279	CcSEcCtD
Pemetrexed—Erythema—Carmustine—brain cancer	0.00128	0.00278	CcSEcCtD
Pemetrexed—Malnutrition—Carmustine—brain cancer	0.00128	0.00278	CcSEcCtD
Pemetrexed—Nervous system disorder—Hydroxyurea—brain cancer	0.00127	0.00275	CcSEcCtD
Pemetrexed—Infestation—Etoposide—brain cancer	0.00127	0.00275	CcSEcCtD
Pemetrexed—Infestation NOS—Etoposide—brain cancer	0.00127	0.00275	CcSEcCtD
Pemetrexed—Thrombocytopenia—Hydroxyurea—brain cancer	0.00127	0.00275	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDK6—brain cancer	0.00127	0.00546	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP2C9—brain cancer	0.00126	0.00544	CbGpPWpGaD
Pemetrexed—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00126	0.00272	CcSEcCtD
Pemetrexed—Alopecia—Temozolomide—brain cancer	0.00126	0.00272	CcSEcCtD
Pemetrexed—Skin disorder—Hydroxyurea—brain cancer	0.00126	0.00272	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Etoposide—brain cancer	0.00125	0.00271	CcSEcCtD
Pemetrexed—Renal failure—Etoposide—brain cancer	0.00125	0.0027	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Etoposide—brain cancer	0.00125	0.00269	CcSEcCtD
Pemetrexed—Myocardial infarction—Etoposide—brain cancer	0.00125	0.00269	CcSEcCtD
Pemetrexed—Erythema—Temozolomide—brain cancer	0.00124	0.00268	CcSEcCtD
Pemetrexed—Malnutrition—Temozolomide—brain cancer	0.00124	0.00268	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—SKP2—brain cancer	0.00124	0.00535	CbGpPWpGaD
Pemetrexed—Stomatitis—Etoposide—brain cancer	0.00124	0.00268	CcSEcCtD
Pemetrexed—Anorexia—Hydroxyurea—brain cancer	0.00124	0.00267	CcSEcCtD
Pemetrexed—Hypersensitivity—Procarbazine—brain cancer	0.00123	0.00267	CcSEcCtD
Pemetrexed—Dysgeusia—Temozolomide—brain cancer	0.00122	0.00263	CcSEcCtD
Pemetrexed—SLC46A1—Disease—DTX2—brain cancer	0.00121	0.0052	CbGpPWpGaD
Pemetrexed—Asthenia—Procarbazine—brain cancer	0.0012	0.0026	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Etoposide—brain cancer	0.0012	0.0026	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.0012	0.00518	CbGpPWpGaD
Pemetrexed—Anaemia—Carmustine—brain cancer	0.00119	0.00257	CcSEcCtD
Pemetrexed—Agranulocytosis—Etoposide—brain cancer	0.00119	0.00256	CcSEcCtD
Pemetrexed—Pruritus—Procarbazine—brain cancer	0.00119	0.00256	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00118	0.0051	CbGpPWpGaD
Pemetrexed—Dyspnoea—Hydroxyurea—brain cancer	0.00116	0.0025	CcSEcCtD
Pemetrexed—Leukopenia—Carmustine—brain cancer	0.00115	0.00249	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.00115	0.00495	CbGpPWpGaD
Pemetrexed—Anaemia—Temozolomide—brain cancer	0.00115	0.00248	CcSEcCtD
Pemetrexed—Diarrhoea—Procarbazine—brain cancer	0.00115	0.00248	CcSEcCtD
Pemetrexed—Dyspepsia—Hydroxyurea—brain cancer	0.00114	0.00247	CcSEcCtD
Pemetrexed—DHFR—G1/S Transition—CCNE1—brain cancer	0.00113	0.00488	CbGpPWpGaD
Pemetrexed—Decreased appetite—Hydroxyurea—brain cancer	0.00113	0.00244	CcSEcCtD
Pemetrexed—Urinary tract disorder—Etoposide—brain cancer	0.00113	0.00244	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00112	0.00242	CcSEcCtD
Pemetrexed—Urethral disorder—Etoposide—brain cancer	0.00112	0.00242	CcSEcCtD
Pemetrexed—Fatigue—Hydroxyurea—brain cancer	0.00112	0.00242	CcSEcCtD
Pemetrexed—Leukopenia—Temozolomide—brain cancer	0.00111	0.0024	CcSEcCtD
Pemetrexed—Hypertension—Carmustine—brain cancer	0.00111	0.0024	CcSEcCtD
Pemetrexed—Constipation—Hydroxyurea—brain cancer	0.00111	0.0024	CcSEcCtD
Pemetrexed—Pain—Hydroxyurea—brain cancer	0.00111	0.0024	CcSEcCtD
Pemetrexed—Dizziness—Procarbazine—brain cancer	0.00111	0.0024	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDK6—brain cancer	0.00111	0.00477	CbGpPWpGaD
Pemetrexed—Chest pain—Carmustine—brain cancer	0.00109	0.00236	CcSEcCtD
Pemetrexed—Myalgia—Carmustine—brain cancer	0.00109	0.00236	CcSEcCtD
Pemetrexed—Erythema multiforme—Etoposide—brain cancer	0.00108	0.00233	CcSEcCtD
Pemetrexed—GART—Metabolism—BSG—brain cancer	0.00107	0.00463	CbGpPWpGaD
Pemetrexed—Hypertension—Temozolomide—brain cancer	0.00107	0.00232	CcSEcCtD
Pemetrexed—Eye disorder—Etoposide—brain cancer	0.00107	0.00231	CcSEcCtD
Pemetrexed—Vomiting—Procarbazine—brain cancer	0.00107	0.0023	CcSEcCtD
Pemetrexed—Myalgia—Temozolomide—brain cancer	0.00106	0.00228	CcSEcCtD
Pemetrexed—Arthralgia—Temozolomide—brain cancer	0.00106	0.00228	CcSEcCtD
Pemetrexed—Rash—Procarbazine—brain cancer	0.00106	0.00228	CcSEcCtD
Pemetrexed—Dermatitis—Procarbazine—brain cancer	0.00106	0.00228	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00105	0.00227	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00105	0.00452	CbGpPWpGaD
Pemetrexed—Oedema—Carmustine—brain cancer	0.00105	0.00227	CcSEcCtD
Pemetrexed—Infection—Carmustine—brain cancer	0.00104	0.00225	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00104	0.00448	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—brain cancer	0.00103	0.00443	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PPP1R12A—brain cancer	0.00103	0.00443	CbGpPWpGaD
Pemetrexed—Thrombocytopenia—Carmustine—brain cancer	0.00103	0.00222	CcSEcCtD
Pemetrexed—Body temperature increased—Hydroxyurea—brain cancer	0.00103	0.00222	CcSEcCtD
Pemetrexed—Anaphylactic shock—Temozolomide—brain cancer	0.00101	0.00219	CcSEcCtD
Pemetrexed—Oedema—Temozolomide—brain cancer	0.00101	0.00219	CcSEcCtD
Pemetrexed—Alopecia—Etoposide—brain cancer	0.00101	0.00218	CcSEcCtD
Pemetrexed—Infection—Temozolomide—brain cancer	0.00101	0.00218	CcSEcCtD
Pemetrexed—DHFR—G1/S Transition—PCNA—brain cancer	0.001	0.00433	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.001	0.00432	CbGpPWpGaD
Pemetrexed—Anorexia—Carmustine—brain cancer	0.001	0.00216	CcSEcCtD
Pemetrexed—Nausea—Procarbazine—brain cancer	0.000996	0.00215	CcSEcCtD
Pemetrexed—Nervous system disorder—Temozolomide—brain cancer	0.000994	0.00215	CcSEcCtD
Pemetrexed—Thrombocytopenia—Temozolomide—brain cancer	0.000992	0.00214	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000992	0.00427	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—CCNE1—brain cancer	0.000989	0.00426	CbGpPWpGaD
Pemetrexed—Skin disorder—Temozolomide—brain cancer	0.000984	0.00213	CcSEcCtD
Pemetrexed—Dysgeusia—Etoposide—brain cancer	0.000973	0.0021	CcSEcCtD
Pemetrexed—Anorexia—Temozolomide—brain cancer	0.000966	0.00209	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—brain cancer	0.00096	0.00414	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Hydroxyurea—brain cancer	0.000956	0.00207	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Carmustine—brain cancer	0.000955	0.00207	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000955	0.00411	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—RELA—brain cancer	0.000953	0.00411	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00094	0.00405	CbGpPWpGaD
Pemetrexed—Dyspnoea—Carmustine—brain cancer	0.000935	0.00202	CcSEcCtD
Pemetrexed—Asthenia—Hydroxyurea—brain cancer	0.000931	0.00201	CcSEcCtD
Pemetrexed—GART—Metabolism—IDH1—brain cancer	0.000923	0.00398	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000923	0.002	CcSEcCtD
Pemetrexed—Anaemia—Etoposide—brain cancer	0.000918	0.00198	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CDKN2A—brain cancer	0.000914	0.00394	CbGpPWpGaD
Pemetrexed—Decreased appetite—Carmustine—brain cancer	0.000912	0.00197	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000907	0.00391	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Carmustine—brain cancer	0.000905	0.00196	CcSEcCtD
Pemetrexed—Dyspnoea—Temozolomide—brain cancer	0.000904	0.00195	CcSEcCtD
Pemetrexed—Constipation—Carmustine—brain cancer	0.000897	0.00194	CcSEcCtD
Pemetrexed—Pain—Carmustine—brain cancer	0.000897	0.00194	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—PPP1R12A—brain cancer	0.000896	0.00386	CbGpPWpGaD
Pemetrexed—Dyspepsia—Temozolomide—brain cancer	0.000892	0.00193	CcSEcCtD
Pemetrexed—Leukopenia—Etoposide—brain cancer	0.000889	0.00192	CcSEcCtD
Pemetrexed—Diarrhoea—Hydroxyurea—brain cancer	0.000888	0.00192	CcSEcCtD
Pemetrexed—SLC46A1—Disease—HES5—brain cancer	0.000885	0.00381	CbGpPWpGaD
Pemetrexed—Decreased appetite—Temozolomide—brain cancer	0.000881	0.0019	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—PCNA—brain cancer	0.000876	0.00377	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP2C9—brain cancer	0.000875	0.00377	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Temozolomide—brain cancer	0.000875	0.00189	CcSEcCtD
Pemetrexed—Fatigue—Temozolomide—brain cancer	0.000874	0.00189	CcSEcCtD
Pemetrexed—Loss of consciousness—Etoposide—brain cancer	0.000873	0.00189	CcSEcCtD
Pemetrexed—Constipation—Temozolomide—brain cancer	0.000867	0.00187	CcSEcCtD
Pemetrexed—Pain—Temozolomide—brain cancer	0.000867	0.00187	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL2—brain cancer	0.000859	0.0037	CbGpPWpGaD
Pemetrexed—Hypertension—Etoposide—brain cancer	0.000858	0.00185	CcSEcCtD
Pemetrexed—Dizziness—Hydroxyurea—brain cancer	0.000858	0.00185	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Carmustine—brain cancer	0.000858	0.00185	CcSEcCtD
Pemetrexed—Chest pain—Etoposide—brain cancer	0.000846	0.00183	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000846	0.00365	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00084	0.00182	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—brain cancer	0.000838	0.00361	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000835	0.0036	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000833	0.00359	CbGpPWpGaD
Pemetrexed—Abdominal pain—Carmustine—brain cancer	0.000829	0.00179	CcSEcCtD
Pemetrexed—Body temperature increased—Carmustine—brain cancer	0.000829	0.00179	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Temozolomide—brain cancer	0.000829	0.00179	CcSEcCtD
Pemetrexed—Vomiting—Hydroxyurea—brain cancer	0.000825	0.00178	CcSEcCtD
Pemetrexed—Rash—Hydroxyurea—brain cancer	0.000818	0.00177	CcSEcCtD
Pemetrexed—Dermatitis—Hydroxyurea—brain cancer	0.000817	0.00177	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000812	0.0035	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Etoposide—brain cancer	0.000811	0.00175	CcSEcCtD
Pemetrexed—Infection—Etoposide—brain cancer	0.000806	0.00174	CcSEcCtD
Pemetrexed—Urticaria—Temozolomide—brain cancer	0.000805	0.00174	CcSEcCtD
Pemetrexed—Abdominal pain—Temozolomide—brain cancer	0.000801	0.00173	CcSEcCtD
Pemetrexed—Body temperature increased—Temozolomide—brain cancer	0.000801	0.00173	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CDKN2A—brain cancer	0.000797	0.00344	CbGpPWpGaD
Pemetrexed—Thrombocytopenia—Etoposide—brain cancer	0.000794	0.00172	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000794	0.00342	CbGpPWpGaD
Pemetrexed—Skin disorder—Etoposide—brain cancer	0.000788	0.0017	CcSEcCtD
Pemetrexed—Anorexia—Etoposide—brain cancer	0.000773	0.00167	CcSEcCtD
Pemetrexed—Hypersensitivity—Carmustine—brain cancer	0.000773	0.00167	CcSEcCtD
Pemetrexed—Nausea—Hydroxyurea—brain cancer	0.000771	0.00167	CcSEcCtD
Pemetrexed—Asthenia—Carmustine—brain cancer	0.000752	0.00163	CcSEcCtD
Pemetrexed—Hypersensitivity—Temozolomide—brain cancer	0.000747	0.00161	CcSEcCtD
Pemetrexed—ATIC—Metabolism—BSG—brain cancer	0.000744	0.00321	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000738	0.00318	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000731	0.00315	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ENO2—brain cancer	0.00073	0.00315	CbGpPWpGaD
Pemetrexed—Asthenia—Temozolomide—brain cancer	0.000727	0.00157	CcSEcCtD
Pemetrexed—Dyspnoea—Etoposide—brain cancer	0.000723	0.00156	CcSEcCtD
Pemetrexed—Diarrhoea—Carmustine—brain cancer	0.000718	0.00155	CcSEcCtD
Pemetrexed—Pruritus—Temozolomide—brain cancer	0.000717	0.00155	CcSEcCtD
Pemetrexed—Decreased appetite—Etoposide—brain cancer	0.000705	0.00152	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Etoposide—brain cancer	0.0007	0.00151	CcSEcCtD
Pemetrexed—Fatigue—Etoposide—brain cancer	0.000699	0.00151	CcSEcCtD
Pemetrexed—Dizziness—Carmustine—brain cancer	0.000693	0.0015	CcSEcCtD
Pemetrexed—Pain—Etoposide—brain cancer	0.000693	0.0015	CcSEcCtD
Pemetrexed—Constipation—Etoposide—brain cancer	0.000693	0.0015	CcSEcCtD
Pemetrexed—Diarrhoea—Temozolomide—brain cancer	0.000693	0.0015	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CYP2C9—brain cancer	0.000682	0.00294	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000671	0.00289	CbGpPWpGaD
Pemetrexed—Dizziness—Temozolomide—brain cancer	0.00067	0.00145	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00067	0.00289	CbGpPWpGaD
Pemetrexed—Vomiting—Carmustine—brain cancer	0.000667	0.00144	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Etoposide—brain cancer	0.000663	0.00143	CcSEcCtD
Pemetrexed—Rash—Carmustine—brain cancer	0.000661	0.00143	CcSEcCtD
Pemetrexed—Dermatitis—Carmustine—brain cancer	0.000661	0.00143	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000652	0.00281	CbGpPWpGaD
Pemetrexed—DHFR—Disease—DTX2—brain cancer	0.000646	0.00279	CbGpPWpGaD
Pemetrexed—Vomiting—Temozolomide—brain cancer	0.000644	0.00139	CcSEcCtD
Pemetrexed—Urticaria—Etoposide—brain cancer	0.000644	0.00139	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000644	0.00277	CbGpPWpGaD
Pemetrexed—Body temperature increased—Etoposide—brain cancer	0.000641	0.00139	CcSEcCtD
Pemetrexed—Abdominal pain—Etoposide—brain cancer	0.000641	0.00139	CcSEcCtD
Pemetrexed—ATIC—Metabolism—IDH1—brain cancer	0.00064	0.00276	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000639	0.00275	CbGpPWpGaD
Pemetrexed—Rash—Temozolomide—brain cancer	0.000639	0.00138	CcSEcCtD
Pemetrexed—Dermatitis—Temozolomide—brain cancer	0.000638	0.00138	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000638	0.00275	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000631	0.00272	CbGpPWpGaD
Pemetrexed—Nausea—Carmustine—brain cancer	0.000623	0.00135	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—MYC—brain cancer	0.000619	0.00267	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—SIRT1—brain cancer	0.000614	0.00264	CbGpPWpGaD
Pemetrexed—Nausea—Temozolomide—brain cancer	0.000602	0.0013	CcSEcCtD
Pemetrexed—Hypersensitivity—Etoposide—brain cancer	0.000597	0.00129	CcSEcCtD
Pemetrexed—SLC46A1—Disease—IDH1—brain cancer	0.000595	0.00257	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000587	0.00253	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000585	0.00252	CbGpPWpGaD
Pemetrexed—Asthenia—Etoposide—brain cancer	0.000582	0.00126	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—BSG—brain cancer	0.00058	0.0025	CbGpPWpGaD
Pemetrexed—Pruritus—Etoposide—brain cancer	0.000574	0.00124	CcSEcCtD
Pemetrexed—SLC46A1—Disease—HEY1—brain cancer	0.000564	0.00243	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000559	0.00241	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000559	0.00241	CbGpPWpGaD
Pemetrexed—Diarrhoea—Etoposide—brain cancer	0.000555	0.0012	CcSEcCtD
Pemetrexed—SLC46A1—Disease—DLL1—brain cancer	0.000554	0.00239	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TP53—brain cancer	0.000551	0.00238	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.00055	0.00237	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—MYC—brain cancer	0.00054	0.00233	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000538	0.00232	CbGpPWpGaD
Pemetrexed—Dizziness—Etoposide—brain cancer	0.000536	0.00116	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—SKP2—brain cancer	0.000522	0.00225	CbGpPWpGaD
Pemetrexed—Vomiting—Etoposide—brain cancer	0.000516	0.00111	CcSEcCtD
Pemetrexed—Rash—Etoposide—brain cancer	0.000511	0.00111	CcSEcCtD
Pemetrexed—Dermatitis—Etoposide—brain cancer	0.000511	0.0011	CcSEcCtD
Pemetrexed—ATIC—Metabolism—ENO2—brain cancer	0.000506	0.00218	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—IDH1—brain cancer	0.000499	0.00215	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000488	0.0021	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000483	0.00208	CbGpPWpGaD
Pemetrexed—Nausea—Etoposide—brain cancer	0.000482	0.00104	CcSEcCtD
Pemetrexed—DHFR—Disease—HES5—brain cancer	0.000474	0.00204	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000472	0.00203	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SHH—brain cancer	0.000471	0.00203	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ENO2—brain cancer	0.000471	0.00203	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00047	0.00202	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—SKP2—brain cancer	0.000466	0.00201	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDK6—brain cancer	0.000465	0.002	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—CDK4—brain cancer	0.000464	0.002	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—SKP2—brain cancer	0.000455	0.00196	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2C9—brain cancer	0.000455	0.00196	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000455	0.00196	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—MYC—brain cancer	0.000449	0.00194	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000442	0.0019	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDK6—brain cancer	0.000416	0.00179	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000412	0.00178	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—SKP2—brain cancer	0.000407	0.00175	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDK6—brain cancer	0.000406	0.00175	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ENO2—brain cancer	0.000394	0.0017	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—MYC—brain cancer	0.000392	0.00169	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—BSG—brain cancer	0.000387	0.00167	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000386	0.00166	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—brain cancer	0.000379	0.00163	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2C9—brain cancer	0.000366	0.00158	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDK6—brain cancer	0.000363	0.00156	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000353	0.00152	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCNE1—brain cancer	0.00035	0.00151	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—VAV1—brain cancer	0.00034	0.00147	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CG—brain cancer	0.000335	0.00144	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—IDH1—brain cancer	0.000333	0.00143	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—brain cancer	0.00033	0.00142	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—BRCA2—brain cancer	0.000323	0.00139	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IDH1—brain cancer	0.000319	0.00138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2C9—brain cancer	0.000319	0.00138	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCNE1—brain cancer	0.000313	0.00135	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000312	0.00135	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BSG—brain cancer	0.000311	0.00134	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PCNA—brain cancer	0.00031	0.00134	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000309	0.00133	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000306	0.00132	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HEY1—brain cancer	0.000303	0.0013	CbGpPWpGaD
Pemetrexed—DHFR—Disease—DLL1—brain cancer	0.000297	0.00128	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HES1—brain cancer	0.000292	0.00126	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—BRCA2—brain cancer	0.000282	0.00122	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PDGFRA—brain cancer	0.000278	0.0012	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PCNA—brain cancer	0.000277	0.0012	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCNE1—brain cancer	0.000273	0.00118	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000272	0.00117	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BSG—brain cancer	0.000271	0.00117	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PCNA—brain cancer	0.000271	0.00117	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDK4—brain cancer	0.000268	0.00116	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—IDH1—brain cancer	0.000267	0.00115	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ENO2—brain cancer	0.000263	0.00113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ENO2—brain cancer	0.000252	0.00109	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SHH—brain cancer	0.000252	0.00109	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.00025	0.00108	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000245	0.00106	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS2—brain cancer	0.000244	0.00105	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PCNA—brain cancer	0.000242	0.00104	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDK4—brain cancer	0.00024	0.00103	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDK4—brain cancer	0.000234	0.00101	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—IDH1—brain cancer	0.000233	0.00101	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CG—brain cancer	0.000232	0.001	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APC—brain cancer	0.000216	0.000931	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO2—brain cancer	0.000211	0.000911	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDK4—brain cancer	0.000209	0.000902	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000206	0.000886	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000205	0.000883	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—brain cancer	0.000197	0.000851	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO2—brain cancer	0.000184	0.000795	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—brain cancer	0.000183	0.00079	CbGpPWpGaD
Pemetrexed—DHFR—Disease—VAV1—brain cancer	0.000182	0.000786	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—brain cancer	0.000181	0.000779	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000179	0.000771	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—brain cancer	0.000173	0.000746	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—brain cancer	0.000168	0.000723	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—brain cancer	0.00016	0.000689	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—brain cancer	0.000157	0.000676	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—brain cancer	0.000155	0.000667	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—brain cancer	0.000151	0.000651	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PDGFRA—brain cancer	0.000149	0.000644	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CTNNB1—brain cancer	0.000147	0.000632	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—brain cancer	0.000139	0.000599	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—brain cancer	0.000135	0.000582	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS2—brain cancer	0.000131	0.000565	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—brain cancer	0.000128	0.000551	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—brain cancer	0.000124	0.000535	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—brain cancer	0.000121	0.000522	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—brain cancer	0.000121	0.00052	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—brain cancer	0.000119	0.000512	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—brain cancer	0.000116	0.000501	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—brain cancer	0.000116	0.000499	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—brain cancer	0.000108	0.000467	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—brain cancer	0.000102	0.00044	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—brain cancer	9.7e-05	0.000418	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—brain cancer	8.99e-05	0.000387	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—brain cancer	8.9e-05	0.000384	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—brain cancer	8.46e-05	0.000365	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CTNNB1—brain cancer	7.87e-05	0.000339	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—brain cancer	6.86e-05	0.000295	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—brain cancer	6.37e-05	0.000275	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—brain cancer	6.23e-05	0.000269	CbGpPWpGaD
